Rigel Pharmaceuticals

XNAS: RIGL

Mid-range Performer

Download real time

17.74 0.81 (4.78%)

40.51% Fall from 52W High

133.8K XNAS Volume

XNAS 22 Apr, 2025 5:30 PM (EDT)

317

Market Cap

Below industry Median

2

Beta 1Year

Very High Volatility

Rigel Pharmaceuticals - RIGL - stock price prediction, stock price target, analyst ratings from 6 analysts

Rigel Pharmaceuticals has a share price target of US$ 34, revenue growth forecast of 10.3%, and profit growth estimate of 34.4% for FY25, based on top 6 analyst calls.

Forecaster Screeners